Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
Cancer
|
October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Steven M Yip, Connor Wells, Raphael Moreira, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
European Urology
|
August 26, 2019
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
Shaan Dudani, Jeffrey Graham, J Connor Wells, et al.
European Urology Oncology
|
December 2, 2019
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors
Jeffrey Graham, Amishi Y Shah, J Connor Wells, et al.
Clinical Genitourinary Cancer
|
March 4, 2017
Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
Guillermo De Velasco, Wanling Xie, Frede Donskov, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
European Urology Oncology
|
January 20, 2026
Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Jeffrey Graham, David Maj, et al.
European Urology Oncology
|
November 1, 2023
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Matthew S Ernst, Vishal Navani, et al.
Genome Medicine
|
August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Charles Swanton, James M Larkin, Marco Gerlinger, et al.
Journal of Clinical Medicine
|
February 25, 2022
Expanding the Role of Ultrasound for the Characterization of Renal Masses
Eduard Roussel, Riccardo Campi, Daniele Amparore, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
Cancer
|
October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Steven M Yip, Connor Wells, Raphael Moreira, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
European Urology
|
August 26, 2019
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
Shaan Dudani, Jeffrey Graham, J Connor Wells, et al.
European Urology Oncology
|
December 2, 2019
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors
Jeffrey Graham, Amishi Y Shah, J Connor Wells, et al.
Clinical Genitourinary Cancer
|
March 4, 2017
Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
Guillermo De Velasco, Wanling Xie, Frede Donskov, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
European Urology Oncology
|
January 20, 2026
Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Jeffrey Graham, David Maj, et al.
European Urology Oncology
|
November 1, 2023
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Matthew S Ernst, Vishal Navani, et al.
Genome Medicine
|
August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Charles Swanton, James M Larkin, Marco Gerlinger, et al.
Journal of Clinical Medicine
|
February 25, 2022
Expanding the Role of Ultrasound for the Characterization of Renal Masses
Eduard Roussel, Riccardo Campi, Daniele Amparore, et al.
Page
of 12